Literature DB >> 23248677

Synthesis and antioxidant evaluation of 4-(furan-2-yl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate esters.

M Mansouri1, A Movahedian, M Rostami, A Fassihi.   

Abstract

Biginelli-type pyrimidines contain an interesting moiety which has attracted considerable attention of medicinal chemists in the last few decades. Despite the very diverse pharmacologic effects ascribed to this kind of pyrimidines, there are few reports on the antioxidant evaluation of Biginelli pyrimidines. In this study synthesis of some novel Biginelli-type pyrimidines is reported. The prepared compounds are ester derivatives of 6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate with a simple hetaryl group, furan, at C-4 position of the pyrimidine ring. These compounds were evaluated for free radical and H(2)O(2) scavenging activities. The reducing power of these compounds was also determined. Compound 3c was the most potent one in diphenyl picrylhydrazine scavenging activity assay with the IC(50) of 0.6 mg/ml. The results of reducing power assays proved that 3d and 3e are moderate reducing agents. All of the studied compounds were very weak in scavenging hydrogen peroxide compared with gallic acid.

Entities:  

Keywords:  Biginelli pyrimidines; DPPH scavenging activity; H2O2 scavenging activity; Reducing power assay; Synthesis

Year:  2012        PMID: 23248677      PMCID: PMC3523418     

Source DB:  PubMed          Journal:  Res Pharm Sci        ISSN: 1735-5362


INTRODUCTION

2-Oxo (thioxo)-1,2,3,4-tetrahydropyrimidine is an interesting moiety which has attracted considerable attention of medicinal chemists in the last few decades(1). This chemical entity which is also called 3,4-dihydropyrimidine-2(1H)-one (thione) (DHPM) was introduced to chemistry at the beginning of 1890s by the Italian chemist Pietro Biginelli. A broad range of biological effects, including calcium channel modulation(23), adrenoceptor blocking(4), antitumor(5), antiviral(6), anti-inflammatory(7) and antimicrobial(8) activities have been attributed to this class of heterocyclic compounds. Free radicals with a singlet electron in their structure play an important role in the pathogenesis of various disorders such as cancers, atherosclerosis, diabetes, Alzehimer, Parkinson and diseases related to aging process(910). Several free radicals are formed through the aerobic metabolism in human. Most of them have a central oxygen atom in their structure hence are also called reactive oxygen species (ROS). A large number of reactive species are formed from the reaction of ROS with biological molecules such as polyunsaturated lipids, thiol containing proteins and nitric oxide (NO). Peroxynitrite anion (ONOO-) is an example which is readily formed in the reaction of O2 with NO. This anion is unstable at physiological pH and rapidly decomposes to form potent nitrating and oxidizing species(1112). Endogenous antioxidant mechanisms and exogenous antioxidant compounds are capable of deactivating or neutralizing these reactive species to prevent the irreversible adverse effects that free radicals exert on cells. Gluthation reductase (GSH), superoxide dismutase (SOD) and catalase are three important enzymes in these endogenous mechanisms. Radical scavenging compounds such as α-tocopherol, vitamin C, carotenoids, and poly phenols with herbal origin are some examples of exogenous antioxidant compounds. These enzymes and antioxidant compounds equilibrate the generation and neutralization of free radicals in the normal physiologic conditions. In case of overproduction of free radicals in the body they become insufficient or defective and design of potent and safe antioxidant molecules seems to be necessary to hold this balance again(1314). This accounts for continuing interest in the identification and development of novel antioxidant agents. Molecules with free radical scavenging abilities are the most-studied antioxidant agents. Despite the extensive studies on the pharmacology of Biginelli pyrimidines during the last decades, there are few reports on their antioxidant evaluation. Stefani and coworkers have described the antioxidant activity of ester derivatives of DHPMs containing phenyl or meta-nitrophenyl ring at the C-4 position of the pyrimidine scaffold. All of the provided compounds were antioxidants to some degree according to lipid peroxidation, spectro-fluorimetry using 2′,7′-dichlorofluorescein diacetate (DCHF-DA), and thiol-peroxidase activity assay methods(15). Another report of the antioxidant evaluation of Biginelli pyrimidines describes the ester derivatives of DHPMs substituted by methyl, phenyl, 2-hydroxy-5-bromophenyl, 2-hydroxy-phenyl, and 1-naphthyl at the C-4 position which were subjected to antioxidant evaluations. These compounds were elucidated to be potent antioxidants in terminating cumene oxidation chains by the reaction with cumylperoxy radicals(16). The third report is on the antioxidant power of the fused-ring derivatives of DHPMs. These compounds which cannot be considered as usual Biginelli pyrimidines were studied by diphenyl picrylhydrazine (DPPH) and hydroxyl radical scavenging activity evaluation methods(17). Here, we report the synthesis of some novel Biginelli pyrimidines. They are ester derivatives of 6- methyl -2- thioxo -1 2, 3, 4- tetrahydro pyrimidine-5-carboxylate which have a simple hetaryl group, furan, at the C-4 position of the pyrimidine ring. All of these compounds have at least one labile hydrogen atom in their structure which provides them a radical scavenging potential. The conjugated system present in the structure of these compounds would help the stabilization of the radical formed after reaction with ROS. These compounds are evaluated for DPPH free radical scavenging ability. Reducing power and H2O2 scavenging activity of them are also determined.

MATERIALS AND METHODS

Chemistry

All chemicals used for the synthesis of compounds were supplied by Merck or Sigma. Melting points were determined on a Mettler capillary melting point apparatus and were uncorrected. The IR spectra were recorded with a WQF-510 Ratio Recording FTIR spectrometer as a KBr disc (γ, cm-1). The 1HNMR spectra (DMSO-d6) were recorded on a Bruker 400 MHz spectrometer. Chemical shifts (δ) are reported in ppm downfield from the internal standard tetramethylsilane (TMS). Mass spectra were acquired with a Platform II Mass Spectrometer from Micromass. Electron- impact ionization was performed at an ionizing energy of 70 eV. The purity of the compounds was checked by thin layer chromatography (TLC) on silica gel plate using chloroform and methanol. The procedure for the synthesis of the desired compounds is depicted in Scheme 1.
Scheme 1

Synthesis of 1,2,3,4-tetrahydropyrimidine-5-carboxylate esters

Synthesis of 1,2,3,4-tetrahydropyrimidine-5-carboxylate esters

General procedure for the synthesis of 4-(furan -2- yl) -6- methyl -2- thioxo -1, 2, 3, 4-tetrahydropyrimidine-5-carboxylate esters 3a-e

A mixture of furan-2-carbaldehyde 1 (1 mmole), appropriate acetoacetate ester 2a-e (1 mmole) and thiourea (1.3 mmole) was refluxed in 4 ml of absolute ethanol for 6 h. Ferric chloride (0.2 mmole) was used as a Lewis’ acid. The reaction mixture was filtered off and the solvent was removed under reduced pressure. The residue was purified using salting out method with acetone and petroleum ether as solvents (3a,b) or by column chromatography using chloroform/ methanol as eluent (3c-e).

Antioxidant evaluation

DPPH free radical scavenging assay

This assay was performed after modification of the method described by Blois and coworkers(18). Briefly, 0.1 ml of different concentrations of methanolic solution of standard (0.0005-1.25 mg/ml) or test compounds (0.156, 0.312, 0.625 and 1.25 mg/ml) were added to 2 ml of DPPH methanolic solution (60 mM). The mixture was shaken vigorously and allowed to react at room temperature and in darkness for 5 h. The absorbance of the resulting solution was measured at 517 nm using a UV/Vis spectrophotometer after 5 hours incubation. Scavenging of DPPH free radicals was calculated as: DPPH scavenging activity (%) = [(Ac–At) / Ac] × 100 where, Ac is the absorbance of the control tube (containing all reagents except the test compound), and At is the absorbance of the test tube. Gallic acid was used as the standard at the concentration range of 0.0005-1.25 mg/ml.

Reducing power assay

This assay was done in accordance with SDS modified and pH-optimized ferricyanide method described by Berker and coworkers(19). Briefly, to 0.2 ml of various concentrations (0.125, 0.25, 0.5 mg/ml in DMSO) of test or standard compounds, 1.25 ml of H2O, 50 μL of 1 M hydrochloric acid, 0.3 mL of 1% potassium ferricyanide solution, 0.1 ml of 1% SDS solution and 0.1 ml of 0.2% w/v FeCl3.6H2O (all solutions in water) were added. The mixture was left at room temperature for 30 min and the resulting absorbance was then measured against a blank at 750 nm. The color of the final solution was stable for at least 30 min. The Prussian blue formed in this method did not precipitate due to the stabilizing effect of SDS. Ascorbic acid at the concentration range of 0.006-0.4 mg/ml and gallic acid at the concentration range of 0.0003-0.32 mg/ml were used as standard antioxidant compounds.

Hydrogen peroxide scavenging assay

H2O2 scavenging power was determined according to the method of Ruch and coworkers(20).This method is based on the ability of a compound to convert hydrogen peroxide to water. A 40 mM solution of hydrogen peroxide was prepared in saline phosphate buffer (pH 7.4). 100 μl DMSO solutions of the test compounds or standards at the concentrations of 0.125, 0.25 and 0.5 mg/ml were separately added to 2 ml of the prepared hydrogen peroxide solution and the absorbance was measyred at 230 nm after 10 min against a blank solution. The blank solution was composed of 100 μl DMSO solutions of test compounds or standards and 2 ml of saline phosphate buffer. The hydrogen peroxide scavenging activity for compounds and standards was calculated using the following equation: H2O2 scavenging activity (%) = [ (Ac-At) / Ac ] × 100 where, Ac is the absorbance of the control and At is the absorbance of the tested compounds or standards. Gallic acid at the concentration rang of 0.015-0.25 mg/ml was used as the standard.

RESULTS

1,2,3,4-tetrahydropyrimidine-5-carboxylate esters 3a-e were prepared in 53-65% with condensing furan-2-carbaldehyde 1, appropriate acetoacetate esters 2a-e and thiourea. The condensation reactions were performed in boiling ethanol using ferric chloride as a Lewis’ acid catalyst (Scheme 1). Structural details and some of the characterization data of the final compounds are summarized in Table 1.
Table 1

Structural details and some of the characterization data of the final compounds

Structural details and some of the characterization data of the final compounds The structures of title compounds were confirmed by FTIR, and 1HNMR spectroscopy. The details of the spectral data for the prepared compounds are provided in the following. All atoms are numbered sequentially to facilitate the assignment of protons in 1HNMR (Table 1).

Methyl 4-(furan-2-yl)-6-methyl-2-thioxo-1, 2, 3, 4-tetrahydropyrimidine -5- carboxylate (3a)

IR: (KBr) γcm-1: 3313, 3184 (NH), 3107 (C-H, Aromatic), 3001, 2984 (C-H, Aliphatic), 1662 (C=O, ester), 1572, 1442 (C=C, aromatic); 1HNMR (DMSO-D6): δ 2.34 (s, 3H, C6-CH3), 3.65 (s, 3H, OCH3), 5.29 (d, J=3.6 Hz, 1H, C4-H), 6.20 (d, J=3.2 Hz, 1H, C5′-H), 6.40 (dd, 1H, J=3.2 Hz, 1.6 Hz, 1H, C4′-H), 7.64 (m, , 1H, C3′-H), 9.72 (d, J = 2.0 Hz, 1H, N3-H), 10.48 (s, 1H, N1-H); EI-MS (+) m/z (%): 252.1 (M+, 80), 253.1 (M+ + H+, 27), 254.08 (M+ +2, 12, 34S).

Ethyl 4-(furan-2-yl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (3b)

IR: (KBr) γcm-1: 3317, 3178 (NH), 3120 (C-H, Aromatic), 2964 (C-H, Aliphatic), 1664 (C=O, ester), 1577, 1452 (C=C, aromatic); 1HNMR (DMSO-D6): δ1.19 (t, J=6.8 Hz, 3H,CH2CH), 2.34 (s, 3H, C6-CH3), 4.08-4.14 (m, 2H, CHCH3), 5.29 (d, J=4.0 Hz, 1H, C4-H), 6.20 (d, J=2.8 Hz, 1H, C5′-H), 6.44 (m, 1H, C4′-H), 7.64 (m, 1H, C3′-H), 9.69 (bs, 1H, N3-H), 10.45 (s, 1H, N1-H); EI-MS (+) m/z (%): 266.09 (M+, 68), 267.1 (M+ + H+, 15), 268.09 (M+ +2, 9, 34S).

Iso-Propyl 4-(furan-2-yl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (3c)

IR: (KBr) γcm-1: 3321, 3174 (NH), 3111 (C-H, Aromatic), 2985 (C-H, Aliphatic), 1660 (C=O, ester), 1576, 1452 (C=C, aromatic); 1HNMR (DMSO-D6): δ1.12 (d, J=6.0 Hz, 3H, CH(CH)2), 1.23 (d, J=6.4 Hz, 3H, CH(CH)2), 2.30 (s, 3H, C6-CH3), 4.92 (heptet, , 1H, CH(CH3)2), 5.28 (d, J=4.0 Hz, 1H, C4-H), 6.20 (d, J=3.2 Hz, 1H, C5′-H), 6.44 (m, 1H, 1H, C4′-H), 7.64 (m, 1H, C3′-H), 9.67 (bs, 1H, N3-H), 10.42 (s, 1H, N1-H); EI-MS (+) m/z (%): 280.04 (M+, 85), 281.1 (M+ + H+, 38), 282.1 (M+ +2, 15, 34S).

Tert-Butyl 4 -(furan-2-yl) -6-methy l- 2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (3d)

IR: (KBr) γcm-1: 3167 (NH), 3107 (C-H, Aromatic), 2978 (C-H, Aliphatic), 1705 (C=O, ester), 1653 (C=C alkene), 1591, 1471 (C=C, aromatic); 1HNMR (DMSO-D6): δ1.35 (s, 9H, CH(CH)3), 2.24 (s, 3H, C6-CH3), 5.17 (s, 1H, C4-H), 6.13 (bs, 1H, C5′-H), 6.39 (m, 1H, 1H, C4′-H), 7.58 (bs, 1H, C3′-H), 9.55 (bs, 1H, N3-H), 10.28 (s, 1H, N1-H); ESI EI-MS (+) m/z (%): 294.0 (M+, 100), 295.1 (M+ + H+, 60), 296.1 (M+ +2, 26, 34S).

Benzyl 4- (furan-2-yl) -6- methy l- 2- thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (3e)

IR: (KBr) γcm-1: 3298, 3178 (NH), 3120 (C-H, Aromatic), 2999 (C-H, Aliphatic), 1699 (C=O, ester), 1645 (C=C alkene), 1566 (C=C, aromatic); 1HNMR (DMSO-D6 ): δ 2.30 (s, 3H, C6-CH3), 5.06 (doublet, J=12.8 Hz, Ha, CHaHbC6H5), 5.12 (doublet, J=12.8 Hz,Hb, CHaHbC6H5), 5.27 (d, J=3.6 Hz, 1H, C4-H), 6.11 (d, J=3.2 Hz, 1H, C5′-H), 6.38 (dd, 1H, J=3.2 Hz, 1.6 Hz, 1H, C4′-H), 7.22-7.33 (m, 5H, C6H5), 7.59 (dd, J=1.6, J=0.8, 1H, C3′-H), 9.66 (m, 1H, N3-H), 10.46 (s, 1H, N1-H). The antioxidant potential of the synthesized compounds was assessed using three different methodologies, namely DPPH free radical scavenging, reducing power, and hydrogen peroxide scavenging assays. The DPPH free radical scavenging activity of methanolic solutions of Biginelli derivatives 3a-e was determined in terms of DPPH scavenging percentage. Results of this assay are provided as the percentage of scavenging/concentration in Fig. 1 and as IC50 (mg/ml) in Table 2, respectively.
Fig. 1

% DPPH scavenging activity of compounds 3a-e

Table 2

IC50 values for DPPH scavenging ability of the compounds 3a-e

% DPPH scavenging activity of compounds 3a-e IC50 values for DPPH scavenging ability of the compounds 3a-e Reducing power values for compounds 3a-e are provided diagrammatically in Fig. 2.
Fig. 2

Reducing power activity values for compounds 3a-e

Reducing power activity values for compounds 3a-e The values for hydrogen peroxide scavenging power of compounds Va-f are provided in Fig. 3.
Fig. 3

Values for hydrogen peroxide scavenging power of compounds 3a-e

Values for hydrogen peroxide scavenging power of compounds 3a-e

DISCUSSION

All compounds showed in the IR spectra an absorption band at 1660-1705 cm-1, typical of the stretch vibrations of the carboxylate ester C=O group. The 1HNMR spectra of all final compounds contained a singlet in the δ 2.24-2.34 ppm region belonging to the CH3 protons at the C-6 position. The characteristic peak for the C-4 proton of the 1,2,3,4-tetrahydropyrimidine ring appeared at 5.17-5.29 ppm confirming the formation of this heterocycle. These two peaks are indicatives of the presence of 1,2,3,4-tetrahydropyrimidine ring. A signal with a multiplicity of twelve appeared at 4.08-4.14 ppm belonging to the hydrogens of the methylen part of the ethyl ester group in compound 3b. This multiplicity can be explained by considering the fact that these two hydrogens are prochiral. Two other prochiral hydrogens were observed in compound 3e. In this compound, benzylic hydrogens were the prochiral atoms which appeared as two doublets at 5.06 and 5.12 ppm with large J values of 12.8 and 14.4 Hz, confirming the germinal coupling of the two prochiral hydrogens. The prochiral hydrogens in 3b and 3e are depicted in Fig. 4. Other 1HNMR spectral signals were in accordance with the proposed structures.
Fig. 4

Prochiral hydrogens in 3b and 3e

Prochiral hydrogens in 3b and 3e A freshly prepared DPPH solution exhibits a deep purple color with an absorption maximum at 517 nm. This purple color generally disappears when an antioxidant is present in the medium. Thus, antioxidant molecules can quench DPPH free radicals, by providing hydrogen atoms or by electron donation via a free radical attack on the DPPH molecule, and convert them to colorless product(2122). From the analysis of results for the DPPH free radical scavenging activity of the studied compounds summarized in Fig. 1 and Table 2, we can conclude that the studied compounds were all weaker than the standard antioxidant, gallic acid, in DPPH scavenging activity. Compound 3c was the most potent antioxidant with the IC50 of 0.6 mg/ml. SDS modified and pH optimized ferricyanide method was used to evaluate the reducing power of the compounds. Ferricyanide and ferric chloride (FeCl3) were used as reagents in this method. The reactions provided in the following equation occur in this assay. The production of Fe[Fe(CN)6]- complex results in a blue color whose intensity depends directly on the reducing power of the compounds. Fe3+ + ⇌ Fe2+ + oxidized antioxidant Fe2+ + Fe(CN)63- ⇌ Fe[Fe(CN)6]- Fe(CN)63- + antioxidant ⇌ Fe(CN)64- + oxidized antioxidant Fe(CN)64- + Fe3+Fe[Fe(CN)6]- The results of reducing power assays proved 3d and 3e as the most potent compounds. Both were weaker than the standards, gallic acid and ascorbic acid and could be considered as moderate reducing agents. The method provided by Ruch and coworkers which is based on the ability of a compound to convert hydrogen peroxide to water was used for determination of H2O2 scavenging power. Hydrogen peroxide is a weak oxidizing agent capable of oxidizing the essential thiol (-SH) group of proteins, thus inactivating a few enzymes. It rapidly passes through the cell membranes and inside the cell reacts with Fe2+ to form hydroxyl radical which exerts several toxic effects(23). It is therefore biologically advantageous for cells to control the amount of hydrogen peroxide to prevent oxidative stress conditions. It can be concluded from the results summarized in Figure 3 that all of the studied compounds were very weak compared with gallic acid in scavenging hydrogen peroxide.

CONCLUSION

Biginelli pyrimidines possessing a 2- oxo(thioxo) -1,2,3,4- tetrahydropyrimidine moiety, has attracted considerable attention of medicinal chemists. There are few reports on the antioxidant evaluation of these compounds. In the current study, the synthesis of some novel 4- (furan-2-yl) -6-methyl -2- thioxo-1,2,3,4- tetrahydropyrimidine -5- carboxylate esters is reported. The antioxidant activity of the synthesized compounds was determined. Compound 3c was the most potent antioxidant with the IC50 of 0.6 mg/ml. The results of reducing power assays proved 3d and 3e as the moderate reducing agents. All of the studied compounds were very weak compared with gallic acid in scavenging hydrogen peroxide.
  14 in total

1.  Evaluation of the in vitro antiretroviral potential of some Biginelli-type pyrimidines.

Authors:  R Zabihollahi; R Vahabpour; C Hartoonian; B Sedaghati; S M Sadat; M Soleymani; M Ranjbar; A Fassihi; M R Aghasadeghi; H R Memarian; M Salehi
Journal:  Acta Virol       Date:  2012       Impact factor: 1.162

2.  New chemical tools for investigating human mitotic kinesin Eg5.

Authors:  Emmanuel Klein; Salvatore DeBonis; Bernd Thiede; Dimitrios A Skoufias; Frank Kozielski; Luc Lebeau
Journal:  Bioorg Med Chem       Date:  2007-06-10       Impact factor: 3.641

Review 3.  Biochemical mechanisms for oxygen free radical formation during exercise.

Authors:  B Sjödin; Y Hellsten Westing; F S Apple
Journal:  Sports Med       Date:  1990-10       Impact factor: 11.136

4.  Prevention of cytotoxicity and inhibition of intercellular communication by antioxidant catechins isolated from Chinese green tea.

Authors:  R J Ruch; S J Cheng; J E Klaunig
Journal:  Carcinogenesis       Date:  1989-06       Impact factor: 4.944

5.  In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.

Authors:  J C Barrow; P G Nantermet; H G Selnick; K L Glass; K E Rittle; K F Gilbert; T G Steele; C F Homnick; R M Freidinger; R W Ransom; P Kling; D Reiss; T P Broten; T W Schorn; R S Chang; S S O'Malley; T V Olah; J D Ellis; A Barrish; K Kassahun; P Leppert; D Nagarathnam; C Forray
Journal:  J Med Chem       Date:  2000-07-13       Impact factor: 7.446

Review 6.  Multipotent antioxidants: from screening to design.

Authors:  Hong-Yu Zhang; Da-Peng Yang; Guang-Yan Tang
Journal:  Drug Discov Today       Date:  2006-08       Impact factor: 7.851

7.  Synthesis and antioxidant activity evaluation of new hexahydropyrimido[5,4-c]quinoline-2,5-diones and 2-thioxohexahydropyrimido[5,4-c]quinoline-5-ones obtained by Biginelli reaction in two steps.

Authors:  Lhassane Ismaili; Arulraj Nadaradjane; Laurence Nicod; Catherine Guyon; Alain Xicluna; Jean-François Robert; Bernard Refouvelet
Journal:  Eur J Med Chem       Date:  2007-08-02       Impact factor: 6.514

8.  Iron chelators can protect against oxidative stress through ferryl heme reduction.

Authors:  Brandon J Reeder; Robert C Hider; Michael T Wilson
Journal:  Free Radic Biol Med       Date:  2007-08-21       Impact factor: 7.376

9.  Dihydropyrimidin-(2H)-ones obtained by ultrasound irradiation: a new class of potential antioxidant agents.

Authors:  Hélio A Stefani; Carlindo B Oliveira; Roberta B Almeida; Claudio M P Pereira; Rodolpho C Braga; Rodrigo Cella; Vanessa C Borges; Lucielli Savegnago; Cristina W Nogueira
Journal:  Eur J Med Chem       Date:  2006-03-03       Impact factor: 6.514

10.  Synthesis and anti-inflammatory activity of some [4,6-(4-substituted aryl)-2-thioxo-1,2,3,4-tetrahydro-pyrimidin-5-yl]-acetic acid derivatives.

Authors:  Sushilkumar S Bahekar; Devanand B Shinde
Journal:  Bioorg Med Chem Lett       Date:  2004-04-05       Impact factor: 2.823

View more
  4 in total

1.  Furanoid F-Acid F6 Uniquely Induces NETosis Compared to C16 and C18 Fatty Acids in Human Neutrophils.

Authors:  Meraj A Khan; Cecil Pace-Asciak; Jassim M Al-Hassan; Mohammad Afzal; Yuan Fang Liu; Sosamma Oommen; Bincy M Paul; Divya Nair; Nades Palaniyar
Journal:  Biomolecules       Date:  2018-11-13

2.  Dihydropyrimidinones Against Multiresistant Bacteria.

Authors:  Marisa Castro Jara; Allison Carlos Assunção Silva; Marina Ritter; Adriana Fernandes da Silva; Carolina Lambrecht Gonçalves; Pedro Rassier Dos Santos; Luciano Sisconetto Borja; Cláudio Martin Pereira de Pereira; Patrícia da Silva Nascente
Journal:  Front Microbiol       Date:  2022-03-18       Impact factor: 5.640

3.  Antimicrobial evaluation of some novel derivatives of 3,4-dihydropyrimidine-2(1H)-one.

Authors:  M Jalali; M Mahdavi; H R Memarian; M Ranjbar; M Soleymani; A Fassihi; D Abedi
Journal:  Res Pharm Sci       Date:  2012-10

Review 4.  A mini-review on Biginelli adducts with notable pharmacological properties.

Authors:  Ângelo de Fátima; Taniris C Braga; Leonardo da S Neto; Bruna S Terra; Breno G F Oliveira; Daniel L da Silva; Luzia V Modolo
Journal:  J Adv Res       Date:  2014-11-01       Impact factor: 10.479

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.